Clinical Trials Logo

HPV Vaccine clinical trials

View clinical trials related to HPV Vaccine.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05105711 Completed - HPV Vaccine Clinical Trials

Mobile Coaching to Improve HPV Vaccine Delivery

Start date: June 21, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the feasibility of using Checkup Coach, a mobile coaching intervention, to improve the way that primary care providers recommend HPV vaccination to adolescent patients and their parents. To conduct this feasibility study, the investigators will deliver the Checkup Coach intervention to 20 Kaiser Permanente Washington primary care providers who routinely recommend HPV vaccine to adolescent patients. The investigators will use a single-arm, pre-post design. Participating primary care providers will attend a 1-hour virtual communication workshop and then use a mobile phone app to receive additional coaching for 12 weeks. Providers will complete surveys at three time points: before the communication workshop, immediately after the workshop, and at 12-week follow-up. Surveys will assess changes in providers' self-reported HPV vaccine recommendation practices and beliefs about HPV vaccine and also acceptability of the intervention. The investigators hypothesizes that providers' HPV vaccine communication will improve between baseline and 12-week follow-up.

NCT ID: NCT04711265 Completed - HIV-1-infection Clinical Trials

Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys

Start date: September 2015
Phase:
Study type: Observational

Longitudinal observational cohort study and extension of the MISP ID: 38406 'immunogenicity and safety of quadrivalent human papillomavirus vaccine in HIV-infected pre-adolescent girls and boys in Kenya'.

NCT ID: NCT02993965 Completed - Vaccine Clinical Trials

State Immunization Information Systems to Improve HPV Vaccination Rates

Start date: February 21, 2017
Phase: N/A
Study type: Interventional

The overarching goal of this study is to evaluate the effectiveness, cost-effectiveness and sustainability of utilizing statewide Immunization Information Systems (IIS) to conduct centralized reminder/recall (R/R) to improve Human Papiloma Virus (HPV) vaccination rates among adolescents ages 11-17 (with a more focused look at the new two dose series for 11-14 year olds).